Navigation Links
iCo Therapeutics Closes $1.3 Million Private Placement
Date:2/9/2009

acement. All securities issued in the private placement are subject to a four month hold period. The private placement is subject to regulatory approval, including the approval of the TSX Venture Exchange.

About iCo Therapeutics

iCo Therapeutics Inc. is a Vancouver-based reprofiling company focused on redosing or reformulating drugs with clinical history for new or expanded indications. iCo has exclusive worldwide rights to three products, iCo-007, in Phase I for the treatment of Diabetic Macular Edema, iCo-008, a product with Phase II clinical history to be developed for severe ocular allergies, and iCo-009, an oral formulation of Amphotericin B for sight and life - threatening diseases. iCo-009 also represents a new drug delivery technology with the potential to reprofile other parenteral administered drugs to the oral route of administration. iCo Therapeutics trades on the TSX-Venture exchange under the symbol "ICO". For more information, visit the company website at: www.icotherapeutics.com

    No regulatory authority has approved or disapproved the content of this
    release. The TSX Venture Exchange does not accept responsibility for the
    adequacy or accuracy of this release.

Forward Looking Statements

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on iCo Therapeutics' current beliefs as well as assumptions made by and information currently available to iCo Therapeutics and relate to, among other things, anticipated financial per
'/>"/>

SOURCE iCo Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
2. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
3. Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients
4. Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share
5. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
6. Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
7. Omnitura Therapeutics Announces Private Placement Financing
8. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
9. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
10. CV Therapeutics Statement on Unsolicited Proposal From Astellas
11. Cell Therapeutics Receives Additional NASDAQ Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... ... Matrix Marketing Group, LLC , a leading provider of performance-based marketing services ... account management department as vice president of client services. Amanda Gregory joins the ... delivery expertise to the growing Matrix Marketing Group team in Denver, Colorado. , ...
(Date:6/30/2015)... 2015  Custom Computer Specialists, Inc. ("Custom"), a leading ... silver sponsors of the Primary Care Development Corporation,s ("PCDC") ... lending their support of PCDC,s mission to expand access ... its founding in 1993, PCDC has been a key ... has financed over 100 completed primary care projects, valued ...
(Date:6/30/2015)... 2015  The Dr. Samadi Prostate Cancer Center in ... full suite of new genetic testing methods for men with ... prostate cancer. Dr. Samadi,s Prostate Cancer ... assessing the risk and optimizing the diagnosis of prostate cancer, ... to now offer these revolutionary genetic tests to men with ...
(Date:6/30/2015)... ... 2015 , ... Smarter Alloys today announced a final round ... allows orthodontists to simultaneously apply different forces to different teeth. The additional case ... about taking SmartArch one step closer to commercial availability for orthodontists and dentists,” ...
Breaking Biology Technology:Matrix Marketing Group Expands Client Services Team 2Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 4New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 5New case studies for SmartArch orthodontic archwire paves way to product launch later this year 2
... Nov. 12, 2010 Ardea Biosciences, Inc. (Nasdaq: ... and chief executive officer, will present at the following upcoming ... Healthcare Conference in New York, NY. Presentation: 1:40 p.m. EST on ... Annual Health Care Conference in New York, NY. Presentation: 1:00 ...
... from Thomson Reuters released today shows that the US is no ... kept pace with the increased output from European and Asia-Pacific nations. ... found that research output from the US has been surpassed by ... 40 percent of research papers in the most influential journals(1). By ...
... Cat fanciers everywhere appreciate the gravity-defying grace and exquisite balance ... extend even to the way cats lap milk? Researchers ... domestic and big cats lap and found that felines of ... physical forces. The results will be published in the ...
Cached Biology Technology:Ardea Biosciences to Present at Two Upcoming Investor Conferences 2Ardea Biosciences to Present at Two Upcoming Investor Conferences 3US Dominance in Scientific Research Significantly Challenged by Increased Competition from Europe and Asia, According to Thomson Reuters Study 2Cats show perfect balance even in their lapping 2Cats show perfect balance even in their lapping 3Cats show perfect balance even in their lapping 4
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... challenges Africa faces when it comes to feeding its ... and famine let alone broader food security issues ... these challenges in the longer term is equally important, ... and development. A re-invigorated effort to boost African ...
... Protection Agency issued its first comprehensive report on major ... list, accounting for more than 70 percent of industrial ... Many climate experts have urged power plants and other ... atmosphere and sequester it deep underground a technique ...
... Energy (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ... protein (CETP) mediates the transfer of cholesterol from "good" ... (LDLs). These findings point the way to the design ... could help prevent the development of heart disease. ...
Cached Biology News:Cutting-edge science creating solutions for African agriculture 2Stanford scientist to discuss the challenges and opportunities of carbon sequestration at AAAS 2How good cholesterol turns bad 2How good cholesterol turns bad 3
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
in vitro Translation, Accessory Products...
... SAGE (serial analysis of ... genome-wide expression analysis. Expression profiles ... enough to detect low-abundance transcripts ... novel genes. The I-SAGE Kit ...
Sheep Serum US Origin...
Biology Products: